- Our Company
- CMF & Orthopedics
- Biomedical Manufacturing
- News & Events
OPM in the News
Now viewing articles posted in 2018.
October 1st, 2014
Oxford Performance Materials founder Scott DeFelice discusses the company and the 3D-printing technology it uses to create facial and cranial implants.
August 18th, 2014
Scott DeFelice, CEO of Oxford Performance Materials, explains how 3D materials play a role in cranial and facial surgery
August 13th, 2014
When NASA's Juno satellite blasted off for Jupiter, the 3D printed parts in its final assembly represented just one small step toward manufacturer Lockheed Martin's goal to eventually build an entire spacecraft using additive manufacturing technology. The launch also signified one giant leap toward the use of 3D printing in the aerospace firm's manufacturing processes here on earth.
Replacing body parts with 3D printing: how one company is bringing hope to patients across the globe
August 6th, 2014
The New Economy speaks to OPM's Scott DeFelice, to find out how his company is transforming industries such as healthcare and aerospace through 3D printing.
August 5th, 2014
South Windsor's Oxford Performance Materials Inc. has named two division presidents. Severine Zygmont, whose most recent title was chief operating officer, has been named president of OPM's biomedical division, the company said. Meanwhile, OPM hired Paul Martin as president of its aerospace and industrial division.
June 10th, 2014
What Do Airplane Parts and Skull Implants Have in Common? CPTV's "Made in Connecticut" series profiles Oxford Performance Materials.
August 15th, 2013
YouTube star iJustine visits with Scott DeFelice, founder and CEO of Oxford Performance Materials.
March 7th, 2013
3D printing technology has helped replace 75 percent of a patient's skull with the approval of U.S. regulators. The 3D-printed implant can replace the bone in people's skulls damaged by disease or trauma, according to Oxford Performance Materials. The company announced it had received approval from the U.S. Food and Drug Administration for its skull implant on Feb. 18 — a decision that led to the first U.S. surgical operation on March 4.
March 5th, 2013
The FDA has, for the first time, awarded its 510(k) clearance for an additively manufactured polymer implant. The product, called the OsteoFab Patient Specific Cranial Device (OPSCD), is manufactured by Oxford Performance Materials (OPM) of South Windsor, Connecticut.